
Forbes @Forbes
The startup is approved to conduct a clinical trial on a non-psychedelic form of ketamine for treatment-resistant depression https://t.co/KeA07Zx9Yx — PolitiTweet.org
Created
Wed Jan 12 14:40:07 +0000 2022
Likes
40
Retweets
8
Source
SocialFlow
View Raw Data
JSON DataView on Twitter
Likely AvailableForbes @Forbes
The startup is approved to conduct a clinical trial on a non-psychedelic form of ketamine for treatment-resistant depression https://t.co/KeA07Zx9Yx — PolitiTweet.org